文献速递神经外周血管CT

clot负荷评分对急性缺血性卒中机械取栓前静脉阿替普酶安全性和有效性的影响:一项随机3期试验的亚组分析

Effect of Clot Burden Score on Safety and Efficacy of Intravenous Alteplase Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: A Subgroup Analysis of a Randomized Phase 3 Trial.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-03-07

该研究是DIRECT-MT试验的探索性亚组分析,按术前CTA评估的 clot负荷评分(CBS)将患者分为0-3、4-6、7-10三组,比较直接取栓与桥接取栓的疗效与安全性。结果显示CBS亚组未改变静脉溶栓对功能结局的治疗效应;CBS 4-6组直接取栓与更高的早期再灌注、最终再灌注及更少取栓次数相关;CBS 7-10组桥接取栓的无症状颅内出血率更高。

要点

  • CBS亚组未显示静脉溶栓对mRS分布的治疗效应有修饰作用。
  • CBS 4-6组中直接取栓与更高早期再灌注、最终再灌注及更少取栓次数相关。
  • CBS 7-10组桥接取栓的无症状颅内出血率高于直接取栓(36.8% vs 14.9%)。

核心结论

  • DIRECT-MT的亚组分析提示,血栓负荷并未改变机械取栓前静脉溶栓对CBS亚组功能结局的治疗效应。

研究设计与样本

  • DIRECT-MT随机试验的探索性亚组分析,基于术前CTA将CBS分为0-3、4-6、7-10三组,比较直接取栓与桥接取栓,报告校正共同比值比。

诊断标准与关键数值

  • CBS 0-3组:校正共同比值比1.519(95%CI 0.928-2.486)。
  • CBS 4-6组:校正共同比值比0.924(95%CI 0.635-1.345)。
  • CBS 7-10组:校正共同比值比1.040(95%CI 0.481-2.247)。
  • CBS 4-6组:早期再灌注校正OR 0.3(95%CI 0.1-0.9),最终再灌注校正OR 0.5(95%CI 0.3-0.9),取栓次数校正OR 0.4(95%CI 0.1-0.7)。
  • CBS 7-10组:桥接取栓无症状颅内出血率36.8% vs 直接取栓14.9%(P = .0197)。

临床应用与阅片要点

  • 术前CTA评估的CBS可用于分层分析,但本研究未显示其改变静脉溶栓前机械取栓的治疗效应。
  • CBS 4-6组中直接取栓与更高早期再灌注、最终再灌注及更少取栓次数相关,CBS 7-10组桥接取栓无症状颅内出血率更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Whether thrombus burden in acute ischemic stroke modify the effect of intravenous thrombolysis (IVT) before mechanical thrombectomy (MT) remains uncertain. We aim to investigate the treatment effect of stratified clot burden score (CBS) on the efficacy and safety of direct versus bridging MT.

MATERIALS AND METHODS: This is an exploratory subgroup analysis of a randomized trial evaluating the effect of CBS on clinical outcome in the DIRECT-MT trial. CBS was divided into 3 groups (0-3, 4-6, and 7-10) based on preoperative CTA, where higher scores indicated a lower clot burden. We report the adjusted common odds ratio for a shift toward better outcomes on the mRS after thrombectomy alone compared with combination treatment by stratified CBS groups.

RESULTS: No modification effect of mRS distribution was observed by CBS subgroups (CBS 0-3: adjusted common ratio odds 1.519 [95% CI, 0.928-2.486]; 4-6: 0.924 [0.635-1.345]; 7-10: 1.040 [0.481-2.247]). Patients with CBS 4-6 had a higher rate of early reperfusion (adjusted OR (aOR), 0.3 [95% CI, 0.1-0.9]), final reperfusion (aOR 0.5 [95% CI, 0.3-0.9]), and fewer thrombectomy attempts (aOR 0.4 [95% CI, 0.1-0.7]). Patients with CBS 7-10 had a higher rate of asymptomatic intracranial hemorrhage (14.9% versus 36.8%, P = .0197) for bridging MT. No significant difference was observed in other safety outcomes by trichotomized CBS.

CONCLUSIONS: The subgroup analysis of DIRECT-MT suggested that thrombus burden did not alter the treatment effect of IVT before MT on functional outcomes in CBS subgroups.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Li Z, Zhou Y, Zhang X, et al. Effect of Clot Burden Score on Safety and Efficacy of Intravenous Alteplase Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: A Subgroup Analysis of a Randomized Phase 3 Trial. AJNR Am J Neuroradiol. 2024. PMID: 38388688. doi:10.3174/ajnr.A8134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。